| HOME >> MEDICINE >> TECHNOLOGY |
22,213 Weighted average common shares outstanding - diluted
22,341
21,990
22,316
22,579ABAXIS, INC.Condensed Consolidated Balance Sheets(Unaudited and in thousands)December 31,March 31,20122012Current assets: Cash and cash equivalents
$
47,427
$
45,843 Short-term investments
22,644
21,689 Receivables, net
36,094
30,694 Inventories
25,069
19,597 Prepaid expenses and other current assets
7,067
5,423 Net deferred tax assets, current
4,356
4,151Total current assets
142,657
127,397Long-term investments
21,712
23,442Investment in unconsolidated affiliate
2,613
2,626Property and equipment, net
25,512
24,296Intangible assets, net
3,515
3,990Other assets
97
85Total assets
$
96,106
$
81,836Current liabilities: Accounts payable
$
,536
$
,381 Accrued payroll and related expenses
8,380
6,336 Accrued taxes
229
266 Other accrued liabilities
2,314
1,991 Deferred revenue
1,388
1,212 Warranty reserve
993
1,245Total current liabilities
24,840
17,431Non-current liabilities: Deferred rent
712
641 Net deferred tax liabilities
159
199 Deferred revenue
3,517
2,396 Warranty reserve
473
601 Notes payable, less current portion
707
783Total non-current liabilities
5,568
4,620Total liabilities
30,408
22,051Shareholders' equity: Common stock
117,217
110,063 Retained earnings
48,435
49,697 Accumulat
'/>"/>
| SOURCE Abaxis, Inc. Copyright©2012 PR Newswire. All rights reserved |